Doctor profile · Federal record
Dr. Mitchell Goff, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Salt Lake City, UT
- NPI 1578595153
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4400 S 700 E Ste 200
Salt Lake City, UT 841073053
(801) 264-4444
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- November 26, 2024
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State license (1)
- Utah #7540912-1205
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578595153. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,800
Distinct HCPCS
10
Medicare allowed
$4,775,690
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 8,700 | 34 | $36 | |
J0178 |
Injection, aflibercept, 1 mg | 2,714 | 334 | $874 | |
92134 |
Imaging of retina | 2,124 | 847 | $40 | |
67028 |
Injection of drug into eye | 1,893 | 472 | $124 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 923 | 601 | $126 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 870 | 42 | $236 | |
J3490 |
Unclassified drugs | 428 | 213 | $2,809 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 332 | 33 | $272 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 250 | 204 | $89 | |
Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 250 | 16 | $218 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 2,594. This provider delivers 7.2× the peer median.Open Payments
Industry payments received
All-time total
$55,244
Transactions
62
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 35 | $36,324.25 | |
| Astellas Pharma US Inc | 12 | $9,501.90 | |
| Regeneron Pharmaceuticals, Inc. | 4 | $7,631.83 | |
| EyePoint Pharmaceuticals US, Inc. | 4 | $1,581.73 | |
| Harrow Eye, LLC | 1 | $77.79 | |
| Alimera Sciences, Inc. | 3 | $50.81 | |
| ABBVIE INC. | 1 | $33.63 | |
| Genentech USA, Inc. | 1 | $22.56 | |
| Biogen, Inc. | 1 | $19.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
233
Patients
82
Total drug cost
$9,452
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 108 | 34 | $1,353 |
| Prednisolone Acetate | Generic | 59 | 34 | $2,326 |
| Ketorolac Tromethamine | Generic | 21 | 14 | $875 |
| Dorzolamide Hcl | Generic | 20 | 0 | $276 |
| Simbrinza (Brinzolamide/Brimonidine Tart) | Brand | 13 | 0 | $4,095 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 12 | 0 | $526 |
Frequently asked questions
What is Dr. Mitchell Goff's medical specialty?
Dr. Mitchell Goff practices Retina Specialist (Ophthalmology) Physician in Salt Lake City, UT.
Where does Dr. Mitchell Goff practice?
Dr. Mitchell Goff practices at 4400 S 700 E Ste 200, Salt Lake City, UT 841073053. Office phone: 8012644444.
What is Dr. Mitchell Goff's NPI?
Dr. Mitchell Goff's National Provider Identifier (NPI) is 1578595153, issued by NPPES.
Does Dr. Mitchell Goff accept Medicare assignment?
Yes. Dr. Mitchell Goff accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mitchell Goff commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, aflibercept, 1 mg (HCPCS J0178); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.